EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, BG Medicine's enterprise value is $0.00 Mil.
BG Medicine's EBITDA for the trailing twelve months (TTM) ended in Dec. 2015 was $-5.06 Mil. Therefore, BG Medicine's EV-to-EBITDA for today is 0.00.
The historical rank and industry rank for BG Medicine's EV-to-EBITDA or its related term are showing as below:
BGMD's EV-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 15.23 * Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-25), BG Medicine's stock price is $0.0001.
BG Medicine's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2015 was $-0.720. Therefore, BG Medicine's PE Ratio for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
BG Medicine EV-to-EBITDA Historical Data
The historical data trend for BG Medicine's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BG Medicine's EV-to-EBITDA
For the Medical Instruments & Supplies subindustry, BG Medicine's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BG Medicine's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BG Medicine's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where BG Medicine's EV-to-EBITDA falls into.
BG Medicine EV-to-EBITDA Calculation
BG Medicine's EV-to-EBITDA for today is calculated as:
BG Medicine's current Enterprise Value is $0.00 Mil.
BG Medicine's EBITDA for the trailing twelve months (TTM) ended in Dec. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.06 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BG Medicine (OTCPK:BGMD) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
BG Medicine's PE Ratio for today is calculated as:
BG Medicine's share price for today is $0.0001.
BG Medicine's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.720.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of BG Medicine's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
BG Medicine Inc manufacture and sell diagnostic products that are used to guide the patients suffering from heart failure and related disorders in the United States. It distributes its products such as BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme-linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BGMD has been successfully added to your 